Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 920828, 10 pages
http://dx.doi.org/10.1093/ecam/nep066
Original Article

8-Prenylkaempferol Suppresses Influenza A Virus-Induced RANTES Production in A549 Cells via Blocking PI3K-Mediated Transcriptional Activation of NF-κB and IRF3

1National Research Institute of Chinese Medicine, Taipei 112, Taiwan
2Institute of Life Science, Collage of Science and Engineering, National Taitung University, Taitung, Taiwan
3Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan

Received 10 July 2008; Accepted 3 June 2009

Copyright © 2011 Wen-Fei Chiou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Folkerts, W. W. Busse, F. P. Nijkamp, R. Sorkness, and J. E. Gern, “Virus-induced airway hyperresponsiveness and asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 6, pp. 1708–1720, 1998. View at Google Scholar · View at Scopus
  2. S. Matsukura, F. Kokubu, H. Noda, H. Tokunaga, and M. Adachi, “Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A,” Journal of Allergy and Clinical Immunology, vol. 98, pp. 1080–1087, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Matsukura, F. Kokubu, H. Kubo, T. Tomita, H. Tokunaga, and M. Kadokura, “Expression of RANTES by normal airway epithelial cells after influenza virus infection,” American Journal of Respiratory Cell and Molecular Biology, vol. 18, pp. 255–264, 1998. View at Google Scholar
  4. N.-K. Mak, C.-Y. Leung, X.-Y. Wei et al., “Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells,” Biochemical Pharmacology, vol. 67, no. 1, pp. 167–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H. M. Chang and P. P. H. But, Pharmacology and Applications of Chinese Materia Medica, World Scientific, Singapore, 1987.
  6. S.-C. Ma, J. Du, P. P.-H. But et al., “Antiviral Chinese medicinal herbs against respiratory syncytial virus,” Journal of Ethnopharmacology, vol. 79, no. 2, pp. 205–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Song, Z. Liu, H. Wang et al., “QiHong prevents death in coxsackievirus B3-induced murine myocarditis through inhibition of virus attachment and penetration,” Experimental Biology and Medicine, vol. 232, no. 11, pp. 1441–1448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P.-L. Ding, Z.-X. Liao, H. Huang, P. Zhou, and D.-F. Chen, “(+)-12α-Hydroxysophocarpine, a new quinolizidine alkaloid and related anti-HBV alkaloids from Sophora flavescens,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 5, pp. 1231–1235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. W. Kim, Y. S. Chi, K. H. Son et al., “Effects of sophoraflavanone G, a prenylated flavonoid from Sophora Flavescens, on cyclooxygenase-2 and in vivo inflammatory response,” Archives of Pharmacal Research, vol. 25, no. 3, pp. 329–335, 2002. View at Google Scholar · View at Scopus
  10. S. W. Lee, H. S. Lee, J. Y. Nam et al., “Kurarinone isolated from Sophora flavescens Ait inhibited MCP-1-induced chemotaxis,” Journal of Ethnopharmacology, vol. 97, no. 3, pp. 515–519, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. J. Servant, N. Grandvaux, and J. Hiscott, “Multiple signaling pathways leading to the activation of interferon regulatory factor 3,” Biochemical Pharmacology, vol. 64, no. 5-6, pp. 985–992, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Lin, C. Heylbroeck, P. Genin, P. M. Pitha, and J. Hiscott, “Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription,” Molecular and Cellular Biology, vol. 19, no. 2, pp. 959–966, 1999. View at Google Scholar · View at Scopus
  13. C.-C. Shen, T.-W. Lin, Y.-L. Huang, S.-T. Wan, B.-J. Shien, and C.-C. Chen, “Phenolic constituents of the roots of Sophora flavescens,” Journal of Natural Products, vol. 69, no. 8, pp. 1237–1240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. P. I. Hillerns and M. Wink, “Binding of flavonoids from Sophora flavescens to the rat uterine estrogen receptor,” Planta Medica, vol. 71, no. 11, pp. 1065–1068, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-C. Ko, B.-L. Wei, and W.-F. Chiou, “Dual regulatory effect of plant extracts of Forsythia suspense on RANTES and MCP-1 secretion in influenza A virus-infected human bronchial epithelial cells,” Journal of Ethnopharmacology, vol. 102, no. 3, pp. 418–423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Don, J. F. Liao, L. L. Lin, and W. F. Chiou, “Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of PI3K signaling pathway,” British Journal of Pharmacology, vol. 151, pp. 638–646, 2007. View at Google Scholar
  17. K. Tobita, A. Sugiura, C. Enomoto, and M. Furuyama, “Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin,” Medical Microbiology and Immunology, vol. 162, pp. 9–14, 1975. View at Google Scholar
  18. B. Dérijard, M. Hibi, I.-H. Wu et al., “JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain,” Cell, vol. 76, no. 6, pp. 1025–1037, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. A. T. Palamara, L. Nencioni, K. Aquilano et al., “Inhibition of influenza A virus replication by resveratrol,” Journal of Infectious Diseases, vol. 191, no. 10, pp. 1719–1729, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Ehrhardt, H. Marjuki, T. Wolff et al., “Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence,” Cellular Microbiology, vol. 8, no. 8, pp. 1336–1348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-K. Shin, Q. Liu, S. K. Tikoo, L. A. Babiuk, and Y. Zhou, “Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation,” Journal of General Virology, vol. 88, no. 3, pp. 942–950, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Z.-M. Bian, S. G. Elner, A. Yoshida, and V. M. Elner, “Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression,” Investigative Ophthalmology and Visual Science, vol. 45, no. 6, pp. 1887–1896, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. V. Madrid, M. W. Mayo, J. Y. Reuther, and A. S. Baldwin, “Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogenactivated protein kinase p38,” Journal of Biological Chemistry, vol. 276, pp. 18934–18940, 2001. View at Google Scholar
  24. P. Dhawan, A. B. Singh, D. L. Ellis, and A. Richmond, “Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-κB and tumor progression,” Cancer Research, vol. 62, no. 24, pp. 7335–7342, 2002. View at Google Scholar · View at Scopus
  25. X. Li and G. R. Stark, “NF-κB-dependent signaling pathways,” Experimental Hematology, vol. 30, no. 4, pp. 285–296, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. S. N. Sarkar, K. L. Peters, C. P. Elco, S. Sakamoto, S. Pal, and G. C. Sen, “Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling,” Nature Structural and Molecular Biology, vol. 11, no. 11, pp. 1060–1067, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. L. A. J. O'Neill, “How Toll-like receptors signal: what we know and what we don't know,” Current Opinion in Immunology, vol. 18, no. 1, pp. 3–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. C. E. Becker and L. A. J. O'Neill, “Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs,” Seminars in Immunopathology, vol. 29, no. 3, pp. 239–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Y. Ling, G. Y. Zhang, Z. J. Cui, and C. K. Zhang, “Supercritical fluid extraction of quinolizidine alkaloids from Sophora flavescens Ait. and purification by high-speed counter-current chromatography,” Journal of Chromatography A, vol. 1145, no. 1-2, pp. 123–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Zhang, L. Xu, S.-S. Xiao et al., “Characterization of flavonoids in the extract of Sophora flavescens Ait. by high-performance liquid chromatography coupled with diode-array detector and electrospray ionization mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 44, no. 5, pp. 1019–1028, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. H. J. Shin, H. J. Kim, J. H. Kwak et al., “A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5,” Bioorganic and Medicinal Chemistry Letters, vol. 12, no. 17, pp. 2313–2316, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Wink and P. Ibieta, “Binding of flavonoids from Sophora flavescens to the rat uterine estrogen receptor,” Planta Medica, vol. 71, pp. 1–3, 2005. View at Google Scholar
  33. J. H. Kim, Y. B. Ryu, N. S. Kang et al., “Glycosidase inhibitory flavonoids from Sophora flavescens,” Biological and Pharmaceutical Bulletin, vol. 29, no. 2, pp. 302–305, 2006. View at Publisher · View at Google Scholar · View at Scopus